Baillie Gifford & Co. Takes $101.18 Million Position in Heartflow, Inc. $HTFL

Baillie Gifford & Co. bought a new position in Heartflow, Inc. (NASDAQ:HTFL) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 3,005,998 shares of the company’s stock, valued at approximately $101,182,000. Baillie Gifford & Co. owned 3.60% of Heartflow as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of HTFL. Emerald Mutual Fund Advisers Trust bought a new position in shares of Heartflow in the third quarter worth about $4,418,000. TrueMark Investments LLC bought a new position in shares of Heartflow during the 3rd quarter valued at approximately $918,000. Finally, TFC Financial Management Inc. purchased a new stake in Heartflow in the 3rd quarter worth approximately $40,000.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Stifel Nicolaus upped their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Canaccord Genuity Group lifted their target price on shares of Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Heartflow in a research note on Monday, December 29th. Finally, JPMorgan Chase & Co. raised their price target on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Four investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $38.60.

Heartflow Trading Down 4.0%

Shares of NASDAQ:HTFL opened at $32.16 on Friday. The company has a market capitalization of $2.74 billion and a price-to-earnings ratio of -17.77. The stock’s fifty day moving average is $30.42. Heartflow, Inc. has a fifty-two week low of $25.38 and a fifty-two week high of $41.22.

Insider Activity at Heartflow

In other news, Director Jeffrey C. Lightcap acquired 40,000 shares of the business’s stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the transaction, the director directly owned 40,000 shares in the company, valued at approximately $1,053,600. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.